المختبرات الطبية الأولى

EGFR immunostaining is important in many carcinomas, as tumors expressing this factor have aggressive course with early relapse and poor response to therapy. Treatment with anti-EGFR either alone or in combination of chemotherapy, have shown to be effective in many carcinomas